|
1
|
Berian JR, Cuddy A, Francescatti AB,
O'Dwyer L, Nancy You Y, Volk RJ and Chang GJ: A systematic review
of patient perspectives on surveillance after colorectal cancer
treatment. J Cancer Surviv. 11:542–552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fuccio L, Repici A, Hassan C, Ponchon T,
Bhandari P, Jover R, Triantafyllou K, Mandolesi D, Frazzoni L,
Bellisario C, et al: Why attempt en bloc resection of
non-pedunculated colorectal adenomas? A systematic review of the
prevalence of superficial submucosal invasive cancer after
endoscopic submucosal dissection. Gut. 67:1464–1474. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gkegkes ID, Minis EE and Iavazzo C:
Dermatomyositis and colorectal cancer: A systematic review. Ir J
Med Sci. 187:615–620. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fang JY, Dong HL, Sang XJ, Xie B, Wu KS,
Du PL, Xu ZX, Jia XY and Lin K: Colorectal cancer mortality
characteristics and predictions in China, 1991–2011. Asian Pac J
Cancer Prev. 16:7991–7995. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang HY, Shi JF, Guo LW, Bai YN, Liao XZ,
Liu GX, Mao AY, Ren JS, Sun XJ, Zhu XY, et al: Expenditure and
financial burden for the diagnosis and treatment of colorectal
cancer in China: A hospital-based, multicenter, cross-sectional
survey. Chin J Cancer. 36:412017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ivanova JI, Saverno KR, Sung J, Duh MS,
Zhao C, Cai S, Vekeman F, Peevyhouse A, Dhawan R and Fuchs CS:
Real-world treatment patterns and effectiveness among patients with
metastatic colorectal cancer treated with ziv-aflibercept in
community oncology practices in the USA. Med Oncol. 34:1932017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Väyrynen JP, Tuomisto A, Väyrynen SA,
Klintrup K, Karhu T, Mäkelä J, Herzig KH, Karttunen TJ and Mäkinen
MJ: Preoperative anemia in colorectal cancer: Relationships with
tumor characteristics, systemic inflammation, and survival. Sci
Rep. 8:11262018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tabung FK, Liu L, Wang W, Fung TT, Wu K,
Smith-Warner SA, Cao Y, Hu FB, Ogino S, Fuchs CS, et al:
Association of dietary inflammatory potential with colorectal
cancer risk in men and women. JAMA Oncol. 4:366–373. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gu Y, Chen T, Li G, Yu X, Lu Y, Wang H and
Teng L: lncRNAs: emerging biomarkers in gastric cancer. Future
Oncol. 11:2427–2441. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma N, Li S, Zhang Q, Wang H, Qin H and
Wang S: Long non-coding RNA GAS5 inhibits ovarian cancer cell
proliferation via the control of microRNA-21 and SPRY2 expression.
Exp Ther Med. 16:73–82. 2018.PubMed/NCBI
|
|
11
|
Ma Z, Peng P, Zhou J, Hui B, Ji H, Wang J
and Wang K: Long non-coding RNA SH3PXD2A-AS1 promotes cell
progression partly through epigenetic silencing P57 and KLF2 in
colorectal cancer. Cell Physiol Biochem. 46:2197–2214. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jeong G, Bae H, Jeong D, Ham J, Park S,
Kim HW, Kang HS and Kim SJ: A Kelch domain-containing KLHDC7B and a
long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer
cell proliferation via the interferon signaling pathway. Sci Rep.
8:129222018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zou Y, Zhong Y, Wu J, Xiao H, Zhang X,
Liao X, Li J, Mao X, Liu Y and Zhang F: Long non-coding PANDAR as a
novel biomarker in human cancer: A systematic review. Cell Prolif.
51:e124222018. View Article : Google Scholar
|
|
14
|
Peng W and Fan H: Long non-coding RNA
PANDAR correlates with poor prognosis and promotes tumorigenesis in
hepatocellular carcinoma. Biomed Pharmacother. 72:113–118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rivandi M, Pasdar A, Hamzezadeh L,
Tajbakhsh A, Seifi S, Moetamani-Ahmadi M, Ferns GA and Avan A: The
prognostic and therapeutic values of long noncoding RNA PANDAR in
colorectal cancer. J Cell Physiol. 234:1230–1236. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu M, Liu Z, Li B, Wang G, Li D and Zhu Y:
The high expression of long non-coding RNA PANDAR indicates a poor
prognosis for colorectal cancer and promotes metastasis by EMT
pathway. J Cancer Res Clin Oncol. 143:71–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li M, Zhao LM, Li SL, Li J, Gao B, Wang
FF, Wang SP, Hu XH, Cao J and Wang GY: Differentially expressed
lncRNAs and mRNAs identified by NGS analysis in colorectal cancer
patients. Cancer Med. 7:4650–4664. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dai M, Chen X, Mo S, Li J, Huang Z, Huang
S, Xu J, He B, Zou Y, Chen J, et al: Meta-signature lncRNAs serve
as novel biomarkers for colorectal cancer: Integrated
bioinformatics analysis, experimental validation and diagnostic
evaluation. Sci Rep. 7:465722017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Zhang R and Zhao J: The Novel Long
Noncoding RNA TUSC7 inhibits proliferation by sponging miR-211 in
colorectal cancer. Cell Physiol Biochem. 41:635–644. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren W, Chen S, Liu G, Wang X, Ye H and Xi
Y: TUSC7 acts as a tumor suppressor in colorectal cancer. Am J
Transl Res. 9:4026–4035. 2017.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang ZW, Jia YX, Zhang WJ, Song LJ, Gao
M, Li MJ, Zhao RH, Li J, Zhong YL, Sun QZ, et al:
lncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal
squamous cell carcinoma by competitively regulating DESC1. J Exp
Clin Cancer Res. 37:562018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma XL, Zhu WD, Tian LX, Sun WD, Shang F,
Lin QT and Zhang HQ: Long non-coding RNA TUSC7 expression is
independently predictive of outcome in glioma. Eur Rev Med
Pharmacol Sci. 21:3605–3610. 2017.PubMed/NCBI
|
|
24
|
Qi P, Xu MD, Shen XH, Ni SJ, Huang D, Tan
C, Weng WW, Sheng WQ, Zhou XY and Du X: Reciprocal repression
between TUSC7 and miR-23b in gastric cancer. Int J Cancer.
137:1269–1278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Liu Z, Yao B, Dou C, Xu M, Xue Y,
Ding L, Jia Y, Zhang H, Li Q, et al: Long non-coding RNA TUSC7 acts
a molecular sponge for miR-10a and suppresses EMT in hepatocellular
carcinoma. Tumour Biol. 37:11429–11441. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Jin Y, Ren H, Ma X, Wang B and
Wang Y: Downregulation of the long non-coding RNA TUSC7 promotes
NSCLC cell proliferation and correlates with poor prognosis. Am J
Transl Res. 8:680–687. 2016.PubMed/NCBI
|
|
27
|
Li N, Shi K and Li W: TUSC7: A novel tumor
suppressor long non-coding RNA in human cancers. J Cell Physiol.
233:6401–6407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shang C, Guo Y, Hong Y and Xue YX: Long
non-coding RNA TUSC7, a target of miR-23b, plays tumor-suppressing
roles in human gliomas. Front Cell Neurosci. 10:2352016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li T, Huang H, Shi G, Zhao L, Li T, Zhang
Z, Liu R, Hu Y, Liu H, Yu J, et al: TGF-β1-SOX9 axis-inducible
COL10A1 promotes invasion and metastasis in gastric cancer via
epithelial-to-mesenchymal transition. Cell Death Dis. 9:8492018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song N, Zhong J, Hu Q, Gu T, Yang B, Zhang
J, Yu J, Ma X, Chen Q, Qi J, et al: FGF18 Enhances Migration and
the epithelial-mesenchymal transition in breast Cancer by
regulating Akt/GSK3β/β-catenin signaling. Cell Physiol Biochem.
49:1019–1032. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu YW, Sun M, Xia R, Zhang EB, Liu XH,
Zhang ZH, Xu TP, De W, Liu BR and Wang ZX: LincHOTAIR
epigenetically silences miR34a by binding to PRC2 to promote the
epithelial-to-mesenchymal transition in human gastric cancer. Cell
Death Dis. 6:e18022015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pan C, Yao G, Liu B, Ma T, Xia Y, Wei K,
Wang J, Xu J, Chen L and Chen Y: Long noncoding RNA FAL1 promotes
cell proliferation, invasion and epithelial-mesenchymal transition
through the PTEN/AKT signaling axis in non-small cell lung cancer.
Cell Physiol Biochem. 43:339–352. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li J, Wang YM and Song YL: Knockdown of
long noncoding RNA AB073614 inhibits glioma cell proliferation and
migration via affecting epithelial-mesenchymal transition. Eur Rev
Med Pharmacol Sci. 20:3997–4002. 2016.PubMed/NCBI
|
|
34
|
Zhang W, Yuan W, Song J, Wang S and Gu X:
lncRna CPS1-IT1 suppresses cell proliferation, invasion and
metastasis in colorectal cancer. Cell Physiol Biochem. 44:567–580.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang TH, Yu CC, Lin YS, Chen TC, Yeh CT,
Liang KH, Shieh TM, Chen CY and Hsueh C: Long noncoding RNA
CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by
regulating HIF-1α activity and inhibiting epithelial-mesenchymal
transition. Oncotarget. 7:43588–43603. 2016.PubMed/NCBI
|
|
36
|
Xue J, Liao L, Yin F, Kuang H, Zhou X and
Wang Y: lncRNA AB073614 induces epithelial- mesenchymal transition
of colorectal cancer cells via regulating the JAK/STAT3 pathway.
Cancer Biomark. 21:849–858. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao S, Zhang Y, Zheng X, Tu X, Li H, Chen
J, Zang Y and Zhang J: Loss of MicroRNA-101 promotes epithelial to
mesenchymal transition in hepatocytes. J Cell Physiol.
230:2706–2717. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang X, Zhou Y, Sun AJ and Xue JL: NEAT1
contributes to breast cancer progression through modulating miR-448
and ZEB1. J Cell Physiol. 233:8558–8566. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
de Barrios O, Győrffy B, Fernández-Aceñero
MJ, Sánchez-Tilló E, Sánchez-Moral L, Siles L, Esteve-Arenys A,
Roué G, Casal JI, Darling DS, et al: ZEB1-induced tumourigenesis
requires senescence inhibition via activation of DKK1/mutant
p53/Mdm2/CtBP and repression of macroH2A1. Gut. 66:666–682. 2017.
View Article : Google Scholar : PubMed/NCBI
|
